Greta Gudoityte

Publikationer
Forskningsbidrag
CV
Populärvetenskap och samverkan

Artiklar

Journal article: JOURNAL OF EXPERIMENTAL AND CLINICAL CANCER RESEARCH. 2025;44(1):199
PARP9-PARP13-PARP14 axis tunes colorectal cancer response to radiotherapy
Prokarenkaite R; Kuodyte K; Gudoityte G; Budginaite E; Naumovas D; Strainiene E; Velickevicius K; Dulskas A; Sileika E; Venius J; Tunaitis V; Pivoriunas A; Starkuviene V; Stankevicius V; Suziedelis K
Article: MOLECULAR ONCOLOGY. 2025
Systematic profiling of cancer-fibroblast interactions reveals drug combinations in ovarian cancer
Gudoityte G; Sharma O; Leuenberger L; Wallin E; Fernebro J; Ostling P; Bergstroem R; Lindberg J; Joneborg U; Kallioniemi O; Seashore-Ludlow B
Article: COMMUNICATIONS BIOLOGY. 2025;8(1):303
Evaluating feature extraction in ovarian cancer cell line co-cultures using deep neural networks
Sharma O; Gudoityte G; Minozada R; Kallioniemi OP; Turkki R; Paavolainen L; Seashore-Ludlow B
Article: ISCIENCE. 2025;28(2):111864
Functional-proteomics-based investigation of the cellular response to farnesyltransferase inhibition in lung cancer
Pan Y; Berkovska O; Marathe S; Mermelekas G; Gudoityte G; Wolide AD; Arslan T; Seashore-Ludlow B; Lehtio J; Orre LM
Article: NPJ PRECISION ONCOLOGY. 2023;7(1):111
The drug efficacy testing in 3D cultures platform identifies effective drugs for ovarian cancer patients
Akerlund E; Gudoityte G; Moussaud-Lamodiere E; Lind O; Bwanika HC; Lehti K; Salehi S; Carlson J; Wallin E; Fernebro J; Ostling P; Kallioniemi O; Joneborg U; Seashore-Ludlow B
Article: CELL DEATH & DISEASE. 2022;13(8):714
Multiomics characterization implicates PTK7 in ovarian cancer EMT and cell plasticity and offers strategies for therapeutic intervention
Raivola J; Dini A; Karvonen H; Piki E; Salokas K; Niininen W; Kaleva L; Zhang K; Arjama M; Gudoityte G; Seashore-Ludlow B; Varjosalo M; Kallioniemi O; Hautaniemi S; Murumagi A; Ungureanu D
Journal article: CANCER RESEARCH. 2022;82(12_Supplement):1890
Abstract 1890: Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer
Åkerlund E; Gudoityte G; Lamodiere EM; Carlson J; Wallin E; Fernebro J; Kallioniemi O; Östling P; Joneborg U; Seashore-Ludlow B
Article: CANCERS. 2021;13(14):3604
PFKFB3 Inhibition Sensitizes DNA Crosslinking Chemotherapies by Suppressing Fanconi Anemia Repair
Ninou AH; Lehto J; Chioureas D; Stigsdotter H; Schelzig K; Akerlund E; Gudoityte G; Joneborg U; Carlson J; Jonkers J; Seashore-Ludlow B; Gustafsson NMS

Alla övriga publikationer

Preprint: RESEARCH SQUARE. 2023
The Drug Efficacy Testing in Ex Vivo 3D Cultures (DETECt) platform enables rapid identification of effective drugs and drug combinations for ovarian cancer patients
Seashore-Ludlow B; Åkerlund E; Gudoityte G; Moussaud-Lamodière E; Lind O; Bwanika HC; Lehti K; Saheli S; Carlson J; Wallin E; Fernebro J; Ostling P; Kallioniemi O; Joneborg U
Conference publication: CANCER RESEARCH. 2022;82(12)
Development of the drug efficacy testing in ex vivo 3D cultures (DETECT) platform and its application to functional precision medicine in ovarian cancer
Akerlund E; Gudoityte G; Lamodiere EM; Carlson J; Wallin E; Fernebro J; Kallioniemi O; Ostling P; Joneborg U; Seashore-Ludlow B

Forskningsbidrag

Discovery of Novel Treatment Allocations for Rare Ovarian Cancer Subtypes Using High-Throughput Drug Screening
Robert Lundberg Memorial Foundation 2024
1 July 2024 - 1 July 2025

Anställningar

Assistent Klinisk, Onkologi-Patologi, Karolinska Institutet, 2025-2026
Doktorand, Onkologi-Patologi, Karolinska Institutet, 2021-2025

Artiklar

Alla övriga publikationer

Forskningsbidrag

Anställningar

Nyheter från KI

Kalenderhändelser från KI